NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
December 3, 2025 — Oncotelic Therapeutics reveals new data showing its IV everolimus formulation reduces gastrointestinal toxicity by 67-fold vs oral version, potentially improving cancer treatment tolerability and efficacy.
December 3, 2025 — Lantern Pharma reports positive Phase 1 results for AI-developed cancer drug LP-184, showing safety and efficacy in advanced solid tumors with $10B+ market potential.
December 3, 2025 — Soligenix advances HyBryte™ for rare diseases like cutaneous T-cell lymphoma, addressing a growing crisis in aging America. Learn about its impact on healthcare and policy.
December 3, 2025 — Annovis Bio to present Phase 3 Parkinson's data showing buntanetap reverses cognitive decline in patients with amyloid pathology at 2025 Parkinson Study Group meeting.
December 3, 2025 — Sigyn Therapeutics' CardioDialysis™ addresses 20-fold higher cardiovascular risk in dialysis patients, leveraging existing dialysis infrastructure to target inflammation and cholesterol during treatments.
December 3, 2025 — SouthernMED Pediatrics acquires NiteOwl Pediatric Urgent Care in North Augusta, expanding pediatric services with extended hours and primary care starting January 2026.
December 3, 2025 — Natural Cure Labs surpasses 200,000 customers with 35M capsules sold, earning Inc. 5000 and Stevie Awards for clean-label, science-backed supplements like monolaurin.
December 3, 2025 — CCHR calls for a total ban on electroconvulsive therapy (ECT) after a 2025 survey reveals widespread patient harm and informed consent violations. Learn about risks and legislative efforts.
December 3, 2025 — Klotho Conference 2025 unveils breakthroughs in longevity research, linking Klotho protein to healthspan extension, gene therapy, and disease prevention. Explore key findings and future therapies.
December 2, 2025 — Bryan Therapeutics warns consumers about counterfeit N1o1 and NO2U nitric oxide supplements sold by unauthorized online sellers. Learn how to identify authentic products.
December 2, 2025 — HealthLynked appoints insurance experts Chris Pulos and Jason Bishara to its board, strengthening governance ahead of Nasdaq listing. The AI healthcare network enhances care coordination.
December 2, 2025 — Oncotelic's joint venture Sapu Nano reveals data showing its Deciparticle platform can formulate diverse cancer drugs into nanoparticles, enabling new IV therapies.
December 2, 2025 — Soligenix develops HyBryte™ for rare diseases as aging population faces healthcare challenges. Learn about medical innovation addressing unmet needs in chronic conditions.
December 2, 2025 — Explore the U.S. healthcare crisis, soaring insurance costs, and political impacts. Learn about Astiva Health and BioMedWire's role in disseminating key updates in biotechnology and life sciences sectors.
December 2, 2025 — ABVC BioPharma highlights safety of plant-based ADHD drug ABV-1505 amid concerns about psychiatric polypharmacy. Non-stimulant alternative shows promise in clinical trials.
December 2, 2025 — CTT Pharma CEO outlines 2026 manufacturing plans for micelle thin-film drug delivery technology, including SEC reporting status and NIH partnership updates.
December 1, 2025 — Quantum BioPharma's $700M lawsuit against CIBC and RBC over stock spoofing allegations featured in CTV W5 investigation, impacting Lucid-MS multiple sclerosis treatment development.
December 1, 2025 — HeartBeam faces FDA decision on 12-lead ECG software but sees path forward. Medical tech company developing revolutionary 3D cardiac monitoring technology for portable use.
December 1, 2025 — Soligenix completes enrollment for Phase 3 FLASH2 trial of HyBryte™ for cutaneous T-cell lymphoma (CTCL), a key step toward potential FDA approval of a novel photodynamic therapy.
December 1, 2025 — NanoViricides signs agreement with Only Orphans Cote to pursue orphan drug designations for NV-387, targeting Smallpox and MPox with potential FDA incentives.